Home LiteratureArticle Details
PMID: 10318881 Published · ppublish English Journal Article

Inducing autoimmune disease to treat cancer.

Proceedings of the National Academy of Sciences of the United States of America ·Vol. 96 ·No. 10 ·1999-05-11 ·Pages 5340-2

Pardoll DM

Abstract

暂无摘要

MeSH Terms
Animals Antigens, Neoplasm/immunology Autoimmunity/immunology CD8-Positive T-Lymphocytes/immunology Cancer Vaccines Cytokines/immunology Humans Melanoma/immunology Melanoma, Experimental/immunology,prevention & control Mice
Chemicals
Antigens, Neoplasm Cancer Vaccines Cytokines
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Pardoll D M
References (31)
31 references, click to expand
  1. Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells.
    J Exp Med. 1999 Mar 1;189(5):757-66 PMID: 10049939
  2. CD4 T cells and their role in antitumor immune responses.
    J Exp Med. 1999 Mar 1;189(5):753-6 PMID: 10049938
  3. Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.
    J Exp Med. 1999 Mar 1;189(5):871-6 PMID: 10049951
  4. Immunity to methylcholanthrene-induced sarcomas.
    J Natl Cancer Inst. 1957 Jun;18(6):769-78 PMID: 13502695
  5. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.
    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2982-7 PMID: 10077623
  6. Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.
    Cancer Res. 1981 Feb;41(2):361-75 PMID: 7004632
  7. Unique tumor-specific antigens.
    Annu Rev Immunol. 1988;6:465-83 PMID: 3289573
  8. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.
    Cell. 1992 Nov 13;71(4):587-97 PMID: 1423616
  9. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.
    J Exp Med. 1994 Mar 1;179(3):1005-9 PMID: 8113668
  10. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.
    Science. 1994 Apr 29;264(5159):716-9 PMID: 7513441
  11. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
    J Exp Med. 1994 Jul 1;180(1):35-42 PMID: 8006593
  12. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.
    Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6458-62 PMID: 8022805
  13. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.
    Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9461-5 PMID: 7937789
  14. Self-determinant selection and selective regulation.
    Chem Immunol. 1995;60:1-19 PMID: 7857523
  15. Induction of anti-self-immunity to cure cancer.
    Cell. 1995 Jul 14;82(1):13-7 PMID: 7606778
  16. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.
    Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7976-80 PMID: 7644523
  17. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.
    Science. 1995 Sep 1;269(5228):1281-4 PMID: 7652577
  18. Releasing the brakes on antitumor immune response.
    Science. 1996 Mar 22;271(5256):1691 PMID: 8596929
  19. Enhancement of antitumor immunity by CTLA-4 blockade.
    Science. 1996 Mar 22;271(5256):1734-6 PMID: 8596936
  20. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
    J Exp Med. 1996 Mar 1;183(3):1185-92 PMID: 8642260
  21. Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
    J Exp Med. 1996 May 1;183(5):1965-71 PMID: 8642306
  22. Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.
    J Immunother Emphasis Tumor Immunol. 1996 Jan;19(1):81-4 PMID: 8859727
  23. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes.
    J Exp Med. 1996 Dec 1;184(6):2207-16 PMID: 8976176
  24. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma.
    J Exp Med. 1997 Feb 3;185(3):453-9 PMID: 9053445
  25. Molecular mimicry between non-self, modified self and self in autoimmunity.
    Semin Immunol. 1998 Feb;10(1):25-34 PMID: 9529653
  26. Cancer vaccines.
    Nat Med. 1998 May;4(5 Suppl):525-31 PMID: 9585204
  27. gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand.
    J Exp Med. 1998 Jul 20;188(2):277-86 PMID: 9670040
  28. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.
    Science. 1998 Jul 31;281(5377):703-6 PMID: 9685265
  29. The role of CD4+ T cell responses in antitumor immunity.
    Curr Opin Immunol. 1998 Oct;10(5):588-94 PMID: 9794842
  30. The central role of CD4(+) T cells in the antitumor immune response.
    J Exp Med. 1998 Dec 21;188(12):2357-68 PMID: 9858522
  31. Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes.
    J Exp Med. 1999 Mar 1;189(5):767-78 PMID: 10049940
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
DOI
10.1073/pnas.96.10.5340
Published
1999-05-11
Pages
5340-2
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC33572
Subset
IM
External Links
PubMed source DOI: 10.1073/pnas.96.10.5340 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2